Stay updated on ANIMATE: Nivolumab in Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the ANIMATE: Nivolumab in Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ANIMATE: Nivolumab in Hodgkin Lymphoma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The page revision now shows Revision: v3.3.2 instead of v3.2.0. This appears to be a minor metadata update with no observable changes to the study details or eligibility criteria.
    Difference
    0.1%
    Check dated 2025-11-25T11:25:18.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Removed the generic government funding and NIH operating status notice from the page.
    Difference
    0.4%
    Check dated 2025-11-18T07:01:20.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    No significant additions or deletions were detected; the page content and layout remain unchanged, including the study details, eligibility criteria, and locations.
    Difference
    0.4%
    Check dated 2025-11-03T21:01:08.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Major update: announces a version upgrade to v3.2.0 and publicly states funding-related operational notices, including that the NIH Clinical Center is open and where to check status.
    Difference
    3%
    Check dated 2025-10-06T05:29:49.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    Changed the revision from v3.0.2 to v3.1.0, indicating a minor version update with no other content changes.
    Difference
    0.1%
    Check dated 2025-09-29T03:03:37.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.0.2 (replacing v3.0.1), indicating a minor update to the content; the 'Back to Top' element was removed. No other substantive changes are evident.
    Difference
    0.2%
    Check dated 2025-09-14T19:11:43.000Z thumbnail image

Stay in the know with updates to ANIMATE: Nivolumab in Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ANIMATE: Nivolumab in Hodgkin Lymphoma Clinical Trial page.